Investigation Into Owens & Minor, Inc. (OMI) Announced byHolzer & Holzer, LLC
ATLANTA, June 27, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Owens & Minor, Inc. (“Owens & Minor” or the “Company”) (NYSE: OMI) complied with federal securities laws. On June 24, 2024, Owens & Minor announced that “the Company’s Executive Vice President & Chief Financial Officer, has, at the request of the Company, resigned from his position as an officer of the Company, effective June 21, 2024.” Following this news, the price of the Company’s stock dropped.
If you purchased Owens & Minor stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at cholzer@holzerlaw.com or Joshua Karr, Esq. at jkarr@holzerlaw.com, call our toll-free number at (888) 508-6832, or visit our website at http://holzerlaw.com/case/owens-minor/ to discuss your legal rights.
Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.
CONTACT:
Corey Holzer, Esq.
(888) 508-6832 (toll-free)
cholzer@holzerlaw.com
-
Improving the CAPE 10
-
4 Cheap Mining Stocks
-
CrowdStrike Selloff a Buying Opportunity After Outage
-
Markets Brief: GDP and Inflation Back in the Spotlight
-
What’s Happening in the Markets This Week
-
Can Value Stocks Really Make a Comeback?
-
When Will the Fed Start Cutting Interest Rates?
-
Do Stock Splits Really Matter?
-
Best Innovative Companies to Own: 2024 Edition
-
19 Best Healthcare Companies to Invest In
-
Truist Earnings: Repurchases Resume After Insurance Business Sale and Stronger Capital Ratios
-
After Earnings, Is Charles Schwab Stock a Buy, a Sell, or Fairly Valued?
-
Verizon Earnings: Cash Flow Looks a Touch Weak Despite Solid Wireless Growth
-
3 High Dividend Stocks to Buy Before They Become Too Expensive
-
10 Best Blue-Chip Stocks to Buy for the Long Term
-
Fifth Third Earnings: Solid Net Interest Margin, but Loan Demand Softens